Rachel W. Linnemann
Harvard University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Rachel W. Linnemann.
Pediatrics | 2016
Kohei Hasegawa; Rachel W. Linnemann; Jonathan M. Mansbach; Nadim J. Ajami; Janice A. Espinola; Joseph F. Petrosino; Pedro A. Piedra; Michelle D. Stevenson; Ashley F. Sullivan; Amy D. Thompson; Carlos A. Camargo
BACKGROUND: Little is known about the association of gut microbiota, a potentially modifiable factor, with bronchiolitis in infants. We aimed to determine the association of fecal microbiota with bronchiolitis in infants. METHODS: We conducted a case–control study. As a part of multicenter prospective study, we collected stool samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 115 age-matched healthy controls. By applying 16S rRNA gene sequencing and an unbiased clustering approach to these 155 fecal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. RESULTS: Overall, the median age was 3 months, 55% were male, and 54% were non-Hispanic white. Unbiased clustering of fecal microbiota identified 4 distinct profiles: Escherichia-dominant profile (30%), Bifidobacterium-dominant profile (21%), Enterobacter/Veillonella-dominant profile (22%), and Bacteroides-dominant profile (28%). The proportion of bronchiolitis was lowest in infants with the Enterobacter/Veillonella-dominant profile (15%) and highest in the Bacteroides-dominant profile (44%), corresponding to an odds ratio of 4.59 (95% confidence interval, 1.58–15.5; P = .008). In the multivariable model, the significant association between the Bacteroides-dominant profile and a greater likelihood of bronchiolitis persisted (odds ratio for comparison with the Enterobacter/Veillonella-dominant profile, 4.24; 95% confidence interval, 1.56–12.0; P = .005). In contrast, the likelihood of bronchiolitis in infants with the Escherichia-dominant or Bifidobacterium-dominant profile was not significantly different compared with those with the Enterobacter/Veillonella-dominant profile. CONCLUSIONS: In this case–control study, we identified 4 distinct fecal microbiota profiles in infants. The Bacteroides-dominant profile was associated with a higher likelihood of bronchiolitis.
Journal of Cystic Fibrosis | 2016
Rachel W. Linnemann; Patricia J. O'Malley; Deborah Friedman; Anna M. Georgiopoulos; David Buxton; Lily L. Altstein; Leonard Sicilian; Allen Lapey; Gregory S. Sawicki; Samuel M. Moskowitz
BACKGROUND Primary palliative care refers to basic skills that all healthcare providers can employ to improve quality of life for patients at any stage of disease. Training in these core skills is not commonly provided to clinicians caring for cystic fibrosis (CF) patients. The objective of this study was to assess change in comfort with core skills among care team members after participation in CF-specific palliative care training focused on management of burdensome symptoms and difficult conversations. METHODS A qualitative needs assessment was performed to inform the development of an 18-hour curriculum tailored to the chronicity and complexity of CF care. A 32-question pre- and post-course survey assessed CF provider comfort with the targeted palliative care skills in 5 domains using a 5-point Likert scale (1=very uncomfortable, 3=neutral, 5=very comfortable). RESULTS Among course participants (n=16), mean overall comfort score increased by 0.9, from 3 (neutral) to 3.9 (comfortable) (p<0.001). Mean comfort level increased significantly (range 0.8 to 1.4) in each skill domain: use of supportive care resources, pain management, non-pain symptom management, communication, and psychosocial skills. CONCLUSIONS CF-specific palliative care training was well received by participants and significantly improved self-assessed comfort with core skills.
Pediatrics International | 2017
Kohei Hasegawa; Rachel W. Linnemann; Jonathan M. Mansbach; Nadim J. Ajami; Janice A. Espinola; Lauren Fiechtner; J. Petrosino; Carlos A. Camargo
Early‐life exposure to older siblings is associated with a lower risk of asthma. To date, no study has addressed the impact of having siblings on both the airway and fecal microbiota during infancy. The aim of this study was therefore to profile the nasal airway and fecal microbiota in infants, and to examine the association between having siblings and microbiota profile.
Pediatric Infectious Disease Journal | 2017
Kohei Hasegawa; Rachel W. Linnemann; Jonathan M. Mansbach; Nadim J. Ajami; Janice A. Espinola; Joseph F. Petrosino; Pedro A. Piedra; Michelle D. Stevenson; Ashley F. Sullivan; Amy D. Thompson; Carlos A. Camargo
Background: Little is known about the relationship of airway microbiota with bronchiolitis in infants. We aimed to identify nasal airway microbiota profiles and to determine their association with the likelihood of bronchiolitis in infants. Methods: A case-control study was conducted. As a part of a multicenter prospective study, we collected nasal airway samples from 40 infants hospitalized with bronchiolitis. We concurrently enrolled 110 age-matched healthy controls. By applying 16S ribosomal RNA gene sequencing and an unbiased clustering approach to these 150 nasal samples, we identified microbiota profiles and determined the association of microbiota profiles with likelihood of bronchiolitis. Results: Overall, the median age was 3 months and 56% were male. Unbiased clustering of airway microbiota identified 4 distinct profiles: Moraxella-dominant profile (37%), Corynebacterium/Dolosigranulum-dominant profile (27%), Staphylococcus-dominant profile (15%) and mixed profile (20%). Proportion of bronchiolitis was lowest in infants with Moraxella-dominant profile (14%) and highest in those with Staphylococcus-dominant profile (57%), corresponding to an odds ratio of 7.80 (95% confidence interval, 2.64–24.9; P < 0.001). In the multivariable model, the association between Staphylococcus-dominant profile and greater likelihood of bronchiolitis persisted (odds ratio for comparison with Moraxella-dominant profile, 5.16; 95% confidence interval, 1.26–22.9; P = 0.03). By contrast, Corynebacterium/Dolosigranulum-dominant profile group had low proportion of infants with bronchiolitis (17%); the likelihood of bronchiolitis in this group did not significantly differ from those with Moraxella-dominant profile in both unadjusted and adjusted analyses. Conclusions: In this case-control study, we identified 4 distinct nasal airway microbiota profiles in infants. Moraxella-dominant and Corynebacterium/Dolosigranulum-dominant profiles were associated with low likelihood of bronchiolitis, while Staphylococcus-dominant profile was associated with high likelihood of bronchiolitis.
Pediatric Allergy and Immunology | 2016
Diana S. Balekian; Rachel W. Linnemann; Victor M. Castro; Roy H. Perlis; Ravi Thadhani; Carlos A. Camargo
Infants hospitalized for bronchiolitis (i.e. severe bronchiolitis) are at increased risk of childhood asthma. There are many known risk factors for severe bronchiolitis, including cardiac and pulmonary diseases. Less is known about the association between atopic diseases and risk of severe bronchiolitis. We sought to further examine risk factors for severe bronchiolitis, focusing on atopic dermatitis (AD).
Journal of Cystic Fibrosis | 2017
Deborah Friedman; Rachel W. Linnemann; Lily L. Altstein; Suhayla Islam; Kieu-Tram Bach; Chelsea Lamb; John Volpe; Caitlin Doolittle; Anita St. John; Patricia J. O'Malley; Gregory S. Sawicki; Anna M. Georgiopoulos; Lael M. Yonker; Samuel M. Moskowitz
BACKGROUND Current palliative care tools do not address distressing chronic symptoms that are most relevant to cystic fibrosis. METHODS A CF-specific structured assessment based on a primary palliative care framework was administered to 41 adolescents and adults with CF. Descriptive and correlational analyses were conducted. RESULTS Patients reported numerous physical and psychological symptoms (mean of 10 per patient), with psychological symptoms rated as more distressing. Anxiety (34%) and depression (44%) were prevalent and correlated with distress attributable to physical symptoms and difficulty with CF self-management, but did not correlate with disease severity. CONCLUSIONS Individuals with CF, regardless of disease severity, face challenges managing symptom burden. Frequently reported symptoms are not consistently associated with distress, suggesting the importance of individualized evaluation. The CF-CARES (Coping, goal Assessment, and Relief from Evolving CF Symptoms) primary palliative care assessment model provides a framework for patients experiencing chronic symptoms to explore interventional options with their clinicians.
Annals of Allergy Asthma & Immunology | 2014
Ashley F. Sullivan; Kohei Hasegawa; Rachel W. Linnemann; Aidan A. Long; Suzanne S. Teuber; Stuart J. Turner; Susanmph Massaro; Carlos A. Camargo
Author(s): Sullivan, Ashley F; Hasegawa, Kohei; Linnemann, Rachel W; Long, Aidan A; Teuber, Suzanne S; Turner, Stuart J; Massaro, Susan; Camargo, Carlos A; MARC-36 Investigators
Journal of Palliative Medicine | 2018
Rachel W. Linnemann; Deborah Friedman; Lily L. Altstein; Suhayla Islam; Kieu-Tram Bach; Anna M. Georgiopoulos; Samuel M. Moskowitz; Lael M. Yonker
BACKGROUND Advance care planning (ACP) is recommended for people with cystic fibrosis (CF), yet guidance for optimal implementation is lacking. OBJECTIVE To assess ACP-related thoughts, comfort level, and preferences among people with CF to guide evidence-based routine implementation of ACP in the CF clinic. DESIGN A cross-sectional survey assessed ACP-related experiences and preferences. SUBJECTS Thirty-eight adolescents and adults with CF from an urban CF center. RESULTS Few subjects reported talking to their CF team about ACP care preferences (5%) or completing advance directives detailing desired medical treatments (11%). However, most participants worried about living with advanced disease (84%) and felt comfortable discussing ACP preferences with CF providers (92%). Subjects largely preferred that ACP conversations occur when they are generally healthy, in the outpatient setting, and with any familiar CF team member. Disease severity was not associated with frequency of worry about living with advanced disease, comfort level with ACP discussions, or ACP setting preferences. CONCLUSIONS People with CF worry about advanced disease and feel comfortable discussing ACP, but need more guidance to understand and document ACP choices. CF patient experiences and preferences support implementation of an early, active approach to ACP for people with CF.
BMC Research Notes | 2015
Kohei Hasegawa; Rachel W. Linnemann; Vasanthi Avadhanula; Jonathan M. Mansbach; Pedro A. Piedra; James E. Gern; Carlos A. Camargo
The Journal of Allergy and Clinical Immunology: In Practice | 2017
Diana S. Balekian; Rachel W. Linnemann; Kohei Hasegawa; Ravi Thadhani; Carlos A. Camargo